Larvol Delta - Bioxodes-obtains-Orphan-Drug-Designation-for-hemorrhagic-stroke-therapeutic-candidate-in-US-and-Europe

BIOX-101 - Bioxodes

https://www.globenewswire.com/news-release/2025/03/05/3037134/0/en/Bioxodes-obtains-Orphan-Drug-Designation-for-hemorrhagic-stroke-therapeutic-candidate-in-US-and-Europe.html

Mar 5, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next